After diagnosing prostate cancer, many sufferers need time to cope with the shock of the disease and the burden of the therapy, but Dr. David Samadi says time is of the essence.

The Most Common Cause Of Death In Men

Prostate cancer is the most common malignant tumor in men. This tumor is even more common than breast cancer in women. It’s the second most common cause of death in men, with nearly 2.9 being diagnosed with the disease.In the early stages of the tumor, it makes no symptoms or discomfort. The only indication of cancer is an elevated level of prostate specific antigens (PSA). Prostate-specific antigen, PSA for short, is a protein that is produced by the glandular cells of the prostate, and that serves to liquefy the semen. Since this protein passes into the bloodstream, even in small amounts, it can easily be detected there by means of a blood sample.

However, there are other causes other than cancer that increase PSA, such as prostate inflammation. But, if the PSA level regularly rises during multiple visits during the check-up, there is strong evidence that it may be a prostate cancer. Dr. David Samadi advises men, starting as young as 40, to get regularly scheduled prostate exams.Usually – but not always – prostate cancer grows slowly over years. Aggressive growth is more common in men who have prostate cancer among those under 60 years of age. A large PSA screening study with more than 160,000 participants, and a mean follow-up of 11 years has shown that prostate cancer screening reduces the chance of death by 29%. Large-scale studies have shown that regular physical activity and a healthy diet can significantly reduce the chances of getting advanced prostate cancer, or even dying from the disease.

Dr. David Samadi is the Chairman of Urology at New York City’s, Lenox Hill Hospital. For more than 20 years, Dr. Samadi has been an international expert on urology diseases, with a focus on prostate cancer. He is often referenced by other experts, and has been published in numerous peer reviewed journals. He is also active in teaching and research on the ground-breaking robotic laparoscopic prostatectomy. Originally from Iran, Dr. Samadi immigrated to London, then New York and grew up in Rosslyn, NY. He attended school at Stony Brook University, earning his B.A. and M.D. degrees, before performing medical residencies at Montefiore Hospital, then Albert Einstein Hospital. Dr. Samadi performed a residency at University hospital of Henri-Mondor More, in France, with a focus on urology diseases.